Hologic, Inc. develops medical technologies focused on women's health, operating across breast cancer detection, cervical cancer screening, and related diagnostics. The company was founded in 1985 and operates in 36 countries with approximately 7,000 employees.
The company's core offerings include mammography systems for early breast cancer detection, diagnostic tests for cervical cancer screening, and surgical instruments designed to support clinical decision-making in women's health procedures. Hologic holds over 4,100 patents across its product portfolio.
Technical work at the company spans medical device engineering, diagnostic imaging, biomedical engineering, and healthcare software - areas where accuracy and reliability are essential to clinical outcomes. The company's approach emphasises precision in both product development and clinical application.
